| | Variaz. | Variaz. 5g. | Variaz. 1 gen. | Variaz. 1anno | Variaz. 3anni | Capi. (M$) |
 | TAKEDA PHARMACEUTICAL COMPANY LIMITED | --.--% | 0.96% | 21.17% | 3.46% | 5.15% | 44 162 |
| | | | | | | |
 | JOHNSON & JOHNSON | 0.89% | -2.41% | -2.05% | -6.63% | 26.71% | 436 680 |
| ELI LILLY AND COMPANY | -1.16% | 3.78% | 12.34% | 13.79% | 175.76% | 298 298 |
| PFIZER, INC. | 0.22% | 0.36% | -15.56% | -1.11% | 41.73% | 279 215 |
 | ROCHE HOLDING AG | -0.71% | 0.65% | -16.74% | -14.21% | 17.36% | 277 502 |
| ABBVIE INC. | 0.18% | 1.39% | 5.28% | 19.13% | 114.17% | 251 582 |
 | NOVO NORDISK A/S | -0.86% | 3.53% | 4.73% | 18.94% | 124.50% | 241 077 |
| MERCK & CO., INC. | -0.01% | 2.38% | 18.20% | 14.92% | 5.11% | 229 515 |
 | ASTRAZENECA PLC | 0.05% | 2.31% | 26.39% | 30.17% | 51.70% | 205 131 |
| NOVARTIS AG | 0.66% | -2.22% | 0.87% | -5.79% | -6.34% | 185 841 |
| BRISTOL-MYERS SQUIBB COMPANY | -0.54% | 0.99% | 18.89% | 7.50% | 56.19% | 159 141 |
| AMGEN INC. | 0.82% | 1.53% | 12.53% | 9.49% | 22.89% | 134 310 |
 | SANOFI | 1.73% | -12.11% | -2.25% | -1.66% | 13.95% | 108 513 |
| GSK PLC | 1.35% | -15.27% | -29.04% | -23.58% | -30.72% | 68 741 |
| DAIICHI SANKYO CO., LTD. | -1.00% | 15.59% | 42.53% | 81.54% | 74.14% | 60 658 |
 | BAYER AG | 1.38% | 1.15% | 15.53% | 13.62% | -13.78% | 53 578 |
| | | | | | | |
| | Media | 0.20% | 0.11% | 6.11% | 10.41% | 44.89% | |
| | Media ponderata per Capi. | 0.06% | 0.39% | 3.97% | 7.10% | 55.21% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
